Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Alcala De Henares – page 2

21 clinical trials in Alcala De Henares, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Alcala De Henares at a glance
21
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

21 trials in Alcala De Henares

Open in trial search

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Felzartamab
  • Sponsor:Biogen Idec Research Limited
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Hospital Universitario La Paz

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Diabetic nephropathy

Not recruiting

Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Bayer AG

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

IgA nephropathy

Not recruiting

Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.

Type 2 diabetes mellitus+2

Not recruiting

Study of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Alcala De Henares

What the registry says about research in the country

01 Oncology Studies

Groundbreaking research focusing on follicular lymphoma and diffuse large B-cell lymphoma treatment approaches, including evaluation of novel therapies like odronextamab and acalabrutinib combinations.

  • Blood cancers and lymphomas
  • Multiple myeloma treatments
  • Colorectal cancer metastases

Studies include assessment of hyperthermic intraoperative chemotherapy for peritoneal metastases.

02 Metabolic Disorders

Comprehensive research on Type 2 Diabetes management, including studies of tirzepatide and innovative combination therapies for patients with concurrent conditions.

  • Diabetes management
  • Obesity treatment
  • Cardiovascular outcomes

Investigations include novel approaches for patients with both diabetes and kidney disease.

03 Nephrology Research

Advanced studies in chronic kidney disease examining innovative treatments like ravulizumab for IgA nephropathy and finerenone for various kidney conditions.

  • IgA Nephropathy
  • Non-diabetic kidney disease
  • End-stage kidney disease

Research includes evaluation of combination therapies and novel treatment approaches.

04 Diagnostic Studies

Evaluation of capsule endoscopy techniques and preparation protocols for improved small bowel visualization and diagnostic accuracy.

  • Endoscopic procedures
  • Mucosal visualization
  • Diagnostic protocols

Focus on improving diagnostic tools and techniques for better patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.